Evidence map›Paper›PMID 32647791›Full record

ArticleHemaSphere2020

Rapid Emergence of Chronic Lymphocytic Leukemia During JAK2 Inhibitor Therapy in a Patient With Myelofibrosis.

Nikolaos Sousos, Gemma Buck, Alba Rodriguez-Meira, Ruggiero Norfo, Angela Hamblin, Francesco Pezzella, Jennifer Davies, Philip Hublitz, Bethan Psaila, Adam J Mead

Erratum issuedOpen access · goldAbstract readLetter
In one paragraph

Article in HemaSphere, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Nikolaos SousosMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Gemma BuckMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Alba Rodriguez-MeiraMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Ruggiero NorfoMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Angela HamblinCancer and Haematology Centre, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Francesco PezzellaCellular Pathology Clinical Service Unit - Haematopathology, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Jennifer DaviesHaematology Department, Wycombe Hospital, Buckinghamshire Healthcare NHS Trust, High Wycombe, UK.
Philip HublitzGenome Engineering Facility, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Bethan PsailaMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Adam J MeadMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
MRC Weatherall Institute of Molecular Medicine · GBUniversity of Oxford · GBBuckinghamshire Healthcare NHS Trust · GBJohn Radcliffe Hospital · GBNIHR Biomedical Research Centre at The Royal Marsden and the ICROxford University Hospitals NHS Trust · GB

Funding

Cancer Research UK 26988Cancer Research UK 28051Cancer Research UK 29034Medical Research Council G0902418Medical Research Council MR/L006340/1Medical Research Council MR/M00919X/1Medical Research Council MR/T014067/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32647791
PMCPMC7306308
OpenAlexW3031137971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.